Health Care Policy
Please respond to each student at least 150 words min and two references each, include their first name in the first sentence accordingly. #1 Health Care Policy Week 13- Discussion 10 Lisandra Ponce de Leon MSN Program Professor: Odiane Medacier Florida National University 07/28/2021 Medical Marijuana Cannabis has a long history for its medicinal use. This medicinal use and otherwise use has increased in demand based on the development of the product. The social advocates have highlighted that legalization of marijuana will lead to the elevation of criminal activities. Fedorova and Lankenau (2017) bring to light the adversities for its use, including and increased contact of the people with illicit drug sellers, loss of taxes, increase in criminal activity, and will prohibit the people from taking advantage of the positive benefits of marijuana. The institutions like American Civil Liberties Union also advocate against the legalization of marijuana. It states that the legalization of marijuana leads to more arrests for marijuana, the people are then less likely to afford a medical representation for it, and such people who misuse marijuana are more in need of financial help. There is evidence in the research that legalization has also heightened marijuana (Makin et al., 2018). The medical evidence for the benefits of marijuana advocates the legalization of the drug. The most immediate use of marijuana is for pain management in treatments like chemotherapy. It has also been used by the for diseases like epilepsy and multiple sclerosis and relief from anxiety, stress, and depression (47%). About 91% of U.S. adults believe marijuana has at least one risk, whereas 9% believe it has no risks (Roditis et al., 2016). Due to these controversial uses, marijuana has been legalized in many countries and states like Canada and Minnesota. Because the science of cannabis is not taught in most nursing schools (except in the context of abuse), nurses must find information about cannabis on their own. And because healthcare professionals generally have little knowledge of cannabis therapeutics, patients frequently seek information from other patients, workers in the cannabis industry, and the Internet. Finding and validating information can be challenging: proper and timely research, however, can inform clinical practice for nurses. References Fedorova, E., & Lankenau, S. (2017). Illicit drug use among young adult marijuana users in Los Angeles: Implications for medical use. Drug And Alcohol Dependence, 171, e62. Makin, D., Willits, D., Koslicki, W., Brooks, R., Dietrich, B., & Bailey, R. (2018). Contextual Determinants of Observed Negative Emotional States in Police-Community Interactions. Criminal Justice And Behavior, 46(2), 301-318. Roditis, M., Delucchi, K., Chang, A., & Halpern-Felsher, B. (2016). Perceptions of social norms and exposure to pro-marijuana messages are associated with adolescent marijuana use. Preventive Medicine, 93, 171-176. #2 Mayrelis Bada Florida National University Health Policy-NGR 5891 Dr.Odiane Medacier July 28, 2021 Discussion 10: Medicinal Marijuana Question 1 There has been a drastic change in in the past decades on the use of medical cannabis. For example, physicians have learned through years of scientific research the benefits of the correct dosage and route of medicinal cannabis provides for cancer and HIV infected patients that are suffering of pain. Thus, there are many stakeholders that support the medicinal marijuana use such as ex-President Barrack Obama who endorsed policy changes within his administration. The U.S. federal government remains its opposition due to the high potential for abuse and trafficking causing current restriction in most states that do not have successfully passed laws to reduce any penalties for medicinal possession. Therefore, some states vary on their laws and regulations because they have not yet been legalized. Question 2 A current research I came across, expresses concern on the heterogeneity. In other words, controlling how much is enough for one individual based on their medical condition. For example, precise data on things such as a standardized dose, regular versus experimental use, heavy use, episodic impairment, or even simultaneous use of marijuana and alcohol are not yet captured in most of the data trafficking systems used to evaluate the impact of these policies, and they are desperately needed (Pacula, 2017). Question 3 Although, some states may be legalized, it is still considered a schedule I substance which it is prohibited by the law. Therefore, some states have established certain protection against arrest for those who are registered to use medicinal marijuana in controlled amounts. However, some forthcoming practice implications are to remove the medicinal marijuana products from schedule I or from the controlled substance list overall. Currently in Florida there isn’t an exact dosing amount but more of a delivery method or routes that are controlled for a period to be consumed for (Risola, 2021). References Pacula, R. L. (2017, May 8). Medical Marijuana and Marijuana Legalization . Retrieved from NCBI: https://www.ncbi.nlm.nih.gov Risola, K. (2021, April 1). Understanding your Florida Medical Cannabis recommendation . Retrieved from Florida Medical Cannabis Clinic : http://www.flmedcannabis.org

Leave a Reply

Your email address will not be published. Required fields are marked *